Reuters - Health Report

Click to View in Browser

Thursday, November 9, 2017

U.S. farm study finds no firm cancer link to Monsanto weedkiller

LONDON, (Reuters) - A large long-term study on the use of the big-selling weedkiller glyphosate by agricultural workers in the United States has found no firm link between exposure to the pesticide and cancer, scientists said on Thursday.

New Delhi declares emergency as toxic smog thickens by the hour

NEW DELHI (Reuters) - The Indian capital declared a pollution emergency and banned the entry of trucks and construction activity as a toxic smog hung over the city for a third day on Thursday and air quality worsened by the hour.

Brazilian Congressional committee votes to ban all abortions

BRASILIA (Reuters) - A Congressional committee led by Evangelical Christians has voted to ban abortion in Brazil in all situations, including cases of rape and where the mother's life is in danger.

Merck KGaA has contacted prospective buyers of consumer health

FRANKFURT (Reuters) - Germany's Merck KGaA said it has sent information documents on its consumer health business to prospective buyers, kicking off an auction, even as a much larger rival business is about to come to market.

Hikma, Vectura in dispute with FDA over generic Advair

LONDON (Reuters) - Hikma and its partner Vectura are in dispute with the Food and Drug Administration over their plans to launch a generic copy of GlaxoSmithKline's popular lung drug Advair in the U.S. market, delaying any eventual approval.

Repeal of individual mandate would increase uninsured, premiums: CBO

WASHINGTON (Reuters) - The Congressional Budget Office said on Wednesday that repealing the Obamacare individual mandate would increase the number of uninsured by 13 million by 2027 and reduce the federal budget deficit less than initially forecast.

Maine governor says he will not expand Medicaid despite vote

(Reuters) - Maine Governor Paul LePage said on Wednesday he would not carry out an expansion of the state's Medicaid program under Obamacare that was approved by voters unless it was fully funded by the legislature, calling it "ruinous" for the state's budget.

Ex-pharma exec Azar is top choice to run U.S. health agency: sources

WASHINGTON (Reuters) - Alex Azar, a former pharmaceutical company executive, is U.S. President Donald Trump's top pick to run the Department of Health and Human Services, two sources with knowledge of the confidential process said on condition of anonymity on Wednesday.

Thousands of drugs at risk if no Brexit deal, companies warn

(Reuters) - Supplies of thousands of medicines are at risk of disruption if Britain leaves the European Union without a trade deal, European pharmaceutical companies warned on Thursday.

Heart valve replacement success may depend on age, valve type

(Reuters Health) - People who need a heart valve replaced often face a dilemma: should they have a mechanical valve made of graphite or a biological valve derived from a cow or pig? A new study suggests the answer depends on the age of the patient and which of the heart’s valves needs to be replaced.